Post-acute sequelae of COVID (PASC), usually referred to as 'Long COVID'(a phenotype of
COVID-19), is a relatively frequent consequence of SARS-CoV-2 infection, in which …

The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …

Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the highly
pathogenic and highly transmissible human coronavirus that is the causative agent for the …

The SARS-CoV-2 infection was previously associated with the expression of the dopamine
biosynthetic enzyme L-Dopa decarboxylase (DDC). Specifically, a negative correlation was …

Background Antithrombin is considered as one of the accused markers for the development
of thrombosis in patients with COVID-19. Because plasma levels of antithrombin vary in …

目的严重急性呼吸综合征冠状病毒2 (severe acute respiratory syndrome coronavirus 2，
SARS-CoV-2) 又称新型冠状病毒， 其新变异株不断产生， 中国疫情防控压力持续增加 …

Severe manifestations of COVID-19 consist of acute respiratory distress syndrome due to an
initially local reaction leading to a systemic inflammatory response that results in hypoxia …

Heparin-induced thrombocytopenia (HIT) occurs in approximately 3% of patients receiving
heparinoids. About 30–75% of patients with type 2 of HIT develop thrombosis as a result of …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a disease newly discovered in December 2019 …

Uncovering the risk factors for acute respiratory disease coronavirus 2019 (COVID-19)
severity may help to provide a valuable tool for early patient stratification and proper …